Table 1 Patient characteristics in the development and test datasets.
 | Overall (n = 245) | p-value | |
---|---|---|---|
Development dataset (n = 200, 81.6%) | Test dataset (n = 45, 18.4%) | ||
VC, n (%) | 102 (51.0) | 18 (40.0) | 0.243 |
Age, mean ± SD (years) | 72.6 ± 9.56 | 73.7 ± 8.56 | 0.460 |
Female, n (%) | 166 (83.0) | 31 (68.9) | 0.052 |
T-score of BMD, mean ± SD (Lumbar) | -3.08 ± 1.04 | -3.52 ± 1.16 | 0.013* |
Lumbar Fracture, n (%) | 134 (67.0) | 29 (64.4) | 0.878 |
History of medication for osteoporosis, n (%) | |||
 Before OVCF Dx | 42 (21.0) | 8 (17.8) | 0.780 |
 After OVCF Dx | 153 (76.5) | 36 (80.0) | 0.758 |